CORC

在结果中检索

CORC

浏览/检索结果: 共146条，第1-10条 帮助

限定条件                    
已选(0)清除 条数/页：   排序方式：
Prognostic Value of MHC-I, PD-L1 and CD8+TILs Expressions in Patients with Surgically Resected Non-Small Cell Lung Cancer 会议论文
作者:  Ding, X.;  Cui, J.;  Wang, X.
收藏  |  浏览/下载：9/0  |  提交时间：2019/12/05
Impact of ErbB Mutations on Clinical Outcomes in Afatinib- or Erlotinib-Treated Patients with SCC of the Lung 会议论文
作者:  Goss, G.;  Cobo, M.;  Lu, S.;  Syrigos, K.;  Lee, K. H.
收藏  |  浏览/下载：10/0  |  提交时间：2019/12/05
Prognostic Value of MHC-I, PD-L1 and CD8+TILs Expressions in Patients with Surgically Resected Non-Small Cell Lung Cancer 会议论文
作者:  Ding, X.;  Cui, J.
收藏  |  浏览/下载：10/0  |  提交时间：2019/12/05
Tislelizumab Combined With Chemotherapy as First-Line Treatment in Chinese Patients With Advanced Lung Cancer 会议论文
作者:  Cui, J.;  Zhao, J.;  Wang, Z.;  Ma, Z.;  Shu, Y.
收藏  |  浏览/下载：10/0  |  提交时间：2019/12/05
Subgroup analysis of olaparib monotherapy versus chemotherapy by hormone receptor and BRCA mutation status in patients with HER2-negative metastatic breast cancer and a germline BRCA mutation: OlympiAD 会议论文
作者:  Senkus-Konefka, E.;  Domchek, S. M.;  Im, S. A.;  Xu, B.;  Armstrong, A.
收藏  |  浏览/下载：12/0  |  提交时间：2019/12/05
Safety, Pharmacokinetics and Anti-Viral Efficacy of Novel Core Protein Allosteric Modifier GLS4 in Patients with Chronic Hepatitis B: Interim Results from a 48 Weeks Phase 2a Study 会议论文
作者:  Zhang, Hong;  Zhu, Xiaoxue;  Chen, Hong;  Li, Xiaojiao;  Hu, Yue
收藏  |  浏览/下载：11/0  |  提交时间：2019/12/05
Efficacy and Safety of Osimertinib in EGFR T790M-Positive Advanced NSCLC Patients with Brain Metastases (APOLLO Study) 会议论文
作者:  Xing, L.;  Pan, Y.;  Shi, Y.;  Shu, Y.;  Feng, J.
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/05
Investigation and analysis of nutritional status of patients with lung cancer 会议论文
作者:  Chen, X.;  Zhang, L.;  Liu, X.
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05
Analysis of Real-Word Mutations of Lung Cancer Driver Genes in 3081 Patients from China 会议论文
作者:  Sun, M.;  Wang, X.;  Xu, Y.;  Guo, Y.;  Ma, K.
收藏  |  浏览/下载：7/0  |  提交时间：2019/12/05
Second-line afatinib vs erlotinib for patients with squamous cell carcinoma (SCC) of the lung (LUX-Lung 8 [LL8]): analysis of tumour and serum biomarkers and long-term responders 会议论文
作者:  Li, W.;  Gadgeel, S. M.;  Soria, J. C.;  Felip, E.;  Cobo, M.
收藏  |  浏览/下载：6/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace